|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00414037 |
|
Date of registration:
|
19/12/2006 |
|
Primary sponsor: |
|
|
Public title:
|
How do Sleeping Pills Affect Pain in the Brain?
|
|
Scientific title:
|
Subchronic Effects of Eszopiclone (Lunesta) on Pain Behavior and Circuitry in Primary Insomnia |
|
Date of first enrolment:
|
December 2006 |
|
Target sample size:
|
|
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT00414037 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Lindsay Reinhardt, B.S. |
|
Address:
|
|
|
Telephone:
|
858-534-7556 |
|
Email:
|
insomniastudy@gmail.com |
|
Affiliation:
|
|
|
|
Name:
|
Martin P Paulus, M.D. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of California, San Diego |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Age 20-55
- Primary Insomnia
Exclusion Criteria:
- Certain medical conditions/medications
- MRI related
Age minimum:
20 Years
Age maximum:
55 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Primary Insomnia
|
|
Intervention(s)
|
|
Drug: Eszopiclone
|
|
Primary Outcome(s)
|
|
Sleep and pain ratings following 1 week of treatment as compared to baseline
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|